Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage tnfα secretion

Journal of the American Society of Nephrology

Volumn 9, Issue 8, 1998, Pages 1499-1506

  Mackenzie, Ruth K ^a   Holmes, Clifford J ^b   Moseley, Andrew ^a   Jenkins, Jean P ^a   Williams, John D ^a   Coles, Gerald A ^a   Faict, Dirk ^b   Topley, Nicholas ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Baxter R and D Europe   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; DIALYSIS FLUID; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; INFECTION RISK; KIDNEY FAILURE; MALE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL;

EID: 0031904153     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. EDTA: Report on management of renal failure in Europe, XXVI, 1995. Nephrol Dial Transplant 11: 1-32, 1996
2. Davies SJ, Bryan J, Phillips L, Russell GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 498-506, 1996
3. Topley N: Biocompatibility of peritoneal dialysis solutions and host defence. Adv Ren Replace Ther 3: 1-3, 1996
4. Jörres A, Williams JD, Topley N: Peritoneal dialysis solution biocompatibility: Inhibitory mechanisms and recent studies with bicarbonate-buffered peritoneal dialysis solutions. Perit Dial Int 17: S42-S46, 1997
5. Jörres A, Gahl GM, Frei U: Peritoneal dialysis fluid biocompatibility: Does it really matter? Kidney Int 46: S79-S86, 1994
6. Topley N, Williams JD: Effect of peritoneal dialysis on cytokine production by peritoneal cells. Blood Purif 14: 188-197, 1996
7. Holmes CJ: Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 13: 88-94, 1993
8. Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41: 1280-1285, 1992
9. Duwe AK, Vas SI, Weatherhead JW: Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 33: 130-135, 1981
10. 4 and tumor necrosis factor release from leukocytes: Effect of peritoneal dialysate. Nephron 58: 276-282, 1991
11. Jörres A, Jörres D, Topley N, Gahl GM, Mahiout A: Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Nephrol Dial Transplant 6: 495-501, 1991
12. Liberek T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 3: 1508-1515, 1993
13. Liberek T, Topley N, Jörres A, Petersen MM, Coles GA, Gahl GM, Williams JD: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 65: 260-265, 1993
14. Topley N, Alobaidi HM, Davies M, Cole GA, Williams JD, Lloyd D: The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34: 404-411, 1988
15. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 40: 77-79, 1991
16. Cooker LA, Luneburg P, Faict D, Choo C, Holmes CJ: Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags. Perit Dial Int 17: 373-378, 1997
17. Rippe B, Simonsen O, Wieslander A, Landgren C: Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 17: 27-34, 1997
18. Veech RL: The untoward effects of the anions of dialysis fluids. Kidney Int 34: 587-597, 1988
19. Taylor RB, Jappy BM, Neil JM: Kinetics of dextrose degradation under autoclaving conditions. J Pharm Pharmacol 23: 121-129, 1971
20. Heimlich KR, Martin AN: A kinetic study of glucose degradation in acid solution. J Am Pharm Assoc 49: 592-597, 1960
21. Wieslander AP, Andren AHG, Nilsson-Thorell C, Muscalu N, Kjellstrand PTT, Rippe B: Are aldehydes in heat-sterilised peritoneal dialysis fluids toxic in vitro? Perit Dial Int 15: 348-352, 1995
22. Feriani M, Biasioli S, Borin D, Brendolan A, Gargantini L, Chiaramonte S, Fabris A, Ronco C, La Greca GG: Bicarbonate solutions for peritoneal dialysis: A reality. Int J Artif Organs 8: 57-58, 1985
23. Topley N, Kaur D, Petersen MM, Jörres A, Passlick-Deetjen J, Coles GA, Williams JD: Bio-compatibility of bicarbonate-buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function. Kidney Int 49: 1447-1456, 1996
24. Topley N, Kaur D, Petersen MM, Jörres A, Williams JD, Faict D, Holmes CJ: In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial cell and neutrophil function. J Am Soc Nephrol 7: 218-224, 1996
25. Yu AW, Olabi Z, Gupta DK, Zhou FQ, Gandhi VC, Ing TS: Effect of euhydric peritoneal dialysis solutions containing a mixture of bicarbonate and lactate or lactate alone on neutrophilic superoxide production. ASAIO Trans 40: M900-M901, 1994
26. Ing TS, Huie DA, Johnson V, Ryu J, Yu AW, Wong FKM, Zhou FQ: Effects of lactate-based and bicarbonate-based peritoneal dialysis solutions on neutrophilic oxygen consumption. Artif Organs 19: 440-442, 1995
27. Zhou XJ, Yu AW, Zhou FQ, Wong FKM, Ing TS, Vaziri ND: Neutrophil intracellular pH after exposure of neutrophils to a euhydric, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart. Int J Artif Organs 18: 69-72, 1995
28. Zhou XJ, Yu AW, Zhou FQ, Ryu J, Ing TS, Vaziri ND: Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH. Int J Artif Organs 16: 816-819, 1993
29. Dobos GJ, Böhler J, Kuhlmann J, Elsner J, Andre M, Passlick-Deetjen J, Schollmeyer PJ: Bicarbonate-based dialysis solutions preserves granulocyte functions. Perit Dial Int 14: 366-370, 1994
30. Manahan FJ, Ing BL, Chan JC, Gupta DK, Zhou FQ, Pal I, Rahman MA: Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. Artif Organs 13: 495-497, 1989
31. Kristensen SR, Pedersen FB: Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 8: 163-167, 1993
32. Fischer H-P, Schenk U, Kiefer T, Hübel E, Thomas S, Yatzidis H, Mettang T, Kuhlmann U: In vitro effects of bicarbonate-versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. Am J Kidney Dis 26: 924-933, 1995
33. Jörres A, Gahl GM, Topley N, Neubauer A, Ludat K, Müller C, Passlick-Deetjen J: In vitro biocompatibility of alternative CAPD fluids: Comparison of bicarbonate-buffered and glucose polymer-based solutions. Nephrol Dial Transplant 9: 785-790, 1994
34. Gotloib L, Wajsbrot V, Shostak A, Kushnier R: Population analysis of mesothelium in situ and in vivo exposed to bicarbonate-buffered peritoneal dialysis fluid. Nephron 73: 219-227, 1996
35. Coles GA: A randomised controlled trial of a bicarbonate- and bicarbonate/lactate-containing dialysis solution in CAPD. Perit Dial Int 17: 48-51, 1997
36. Feriani M, Dissegna D, La Greca G, Passlick-Deetjen J: Short term clinical study with bicarbonate-containing peritoneal dialysis solution. Perit Dial Int 13: 296-301, 1993
37. Feriani M, Carobi C, La Greca G, Buoncristiani U, Passlick-Deetjen J: Clinical experience with a 39 mmol/l bicarbonate-buffered peritoneal dialysis solution. Perit Dial Int 17: 17-21, 1997
38. Feriani M, Passlick-Deetjen J, La Greca G: Factors affecting bicarbonate transfer with bicarbonate-containing CAPD solution. Perit Dial Int 15: 336-341, 1995
39. Mactier RA, Gokal R, Williams PF, Lindburgh M, Naik RB, Wrege U, Grontoft KC, Larsson R, Berglund J, Sproson TS, Tranaeus A, Faict D: Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 53: 1061-1067, 1998
40. de Fijter CWH, Verbrugh HA, Oe LP, Peters EDJ, Van der Meulen J, Donker AJM, Verhoef J: Peritoneal defence in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 42: 947-950, 1992
41. de Fijter CWH, Verbrugh HA, Oe LP, Heezius E, Donker AJM, Verhoef J, Gokal R: Biocompatibility of a glucose polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 4: 411-418, 1993
42. de Fijter CWH, Verbrugh HA, Peters EDJ, Oe PL, van der Meulen J, Verhoef J, Donker AJM: In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 39: 75-80, 1993
43. de Fijter CWH, Oe LP, Heezius ECJM, Donker AJM, Verbrugh HA: Low-calcium peritoneal dialysis fluid should not impact peritonitis rates in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27: 409-415, 1996
44. Mackenzie RK, Coles GA, Williams JD: Eicosanoid synthesis in human peritoneal macrophages stimulated with S. epidermidis. Kidney Int 37: 1316-1324, 1990
45. Mackenzie RK, Coles GA, Williams JD: The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis 163: 837-842, 1991
46. Mackenzie RK, Coles GA, Topley N, Powell WS, Williams JD: Down regulation of cyclooxygenase product generation by human peritoneal macrophages. Immunology 76: 648-654, 1992
47. Mackenzie RK, Topley N, Neubauer A, Coles GA, Williams JD: Staphylococcal exoproducts down-regulate cyclooxygenase 1 and 2 in peritoneal macrophages. J Lab Clin Med 129: 23-34, 1997
48. Zangerle PF, De Groote D, Lopez M, Meuleman RJ, Vrindts Y, Fauchet F, Dehart I, Jadoul M, Radoux D, Franchimont P: Direct stimulation of cytokines (IL-1β, TNFα, IL-6, IL-2, IFNγ and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 4: 568-575, 1992
49. Topley N: In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions. Perit Dial Int 17: 42-47, 1997
50. Plum J, Fusshöller A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B: In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Nephrol Dial Transplant 12: 1652-1660, 1997
51. Topley N: What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions? Perit Dial Int 15: 205-209, 1995
52. Zemel D, Imholz ALT, de Wart DR, Dinkla C, Struijk DG, Krediet RT: The appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent during stable and infectious CAPD. Kidney Int 46: 1422-1430, 1994
53. Ing TS, Zhou XJ, Yu AW, Vaziri ND: Lactate-containing versus bicarbonate-containing peritoneal dialysis solutions. Perit Dial Int 12: 276-277, 1992
54. Topley N, Williams JD: The role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46: S71-S78, 1994